# [¹¹C]Methionine PET uptake kinetics in corticotroph pituitary neuroendocrine tumors

**Authors:** Anthime Flaus, Armand Pattée, Guillaume Criton, Nicolas Costes, Elise Levigoureux, Julie Haesebaert, Alexandre Vasiljevic, Claire Briet, Claire Briet, Frederic Castinetti, Justine Cristante, Delphine Drui, Natacha Germain, Luigi Maione, Frederic Illouz, Emmanuel Sonnet, Igor Tauveron, Ines Merida, Sophie Lancelot, Lucien Marchand, Sylvie Rode, Mireille Bertholon-Gregoire, Véronique Lapras, Emmanuel Jouanneau, François Cotton, Claire Bournaud, Gerald Raverot

PMC · DOI: 10.1038/s41598-026-39219-7 · Scientific Reports · 2026-02-27

## TL;DR

[¹¹C]Methionine PET scans can better detect pituitary tumors by analyzing early uptake patterns, which differ from normal tissue.

## Contribution

This study explores early [¹¹C]methionine PET uptake kinetics to improve detection of corticotroph pituitary tumors.

## Key findings

- Kinetic analysis showed higher early uptake in pituitary tumors compared to normal tissue.
- Early slope and peak uptake parameters demonstrated moderate-to-high discriminative performance for tumor detection.

## Abstract

[11C]Methionine ([11C]MET) PET provides high sensitivity to localize corticotroph pituitary neuroendocrine tumors (PitNETs) in de novo Cushing’s disease but remains inconclusive in up to 20% of cases. Current PET protocols rely on late acquisitions (20–40 min post-injection). Since other endocrine tumors present earlier peak tracer uptake, corticotroph PitNETs might also exhibit early differential amino acid uptake, compared to the normal pituitary gland. This exploratory study based on data derived from a previously registered prospective multicenter cohort study (ClinicalTrials.gov identifier: NCT03346954) included 15 patients with pathologically confirmed corticotroph PitNETs accurately localized using MRI. Kinetic analysis showed rapid early uptake in PitNETs and normal pituitary gland, followed by a significant decline over time, with consistently higher uptake in PitNETs (p < 0.05), but no statistically significant difference in temporal uptake pattern (p = 0.09). Early uptake slope and peak uptake were significantly higher in PitNETs compared to normal gland (p < 0.01), with moderate-to-high discriminative performance (area under the curve 0.78; 95%CI 0.60–0.94 and 0.86; 95%CI 0.69–0.98, respectively). Time-to-peak showed no statistically significant discriminative value. These findings suggest that kinetic parameters of [¹¹C]MET PET, particularly early slope and peak uptake, may provide complementary information to static PET for PitNET characterization.

The online version contains supplementary material available at 10.1038/s41598-026-39219-7.

## Linked entities

- **Diseases:** Cushing’s disease (MONDO:0009050)

## Full-text entities

- **Diseases:** pituitary neuroendocrine tumors (MESH:D018358)
- **Chemicals:** [11C]Methionine (MESH:C086242)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12988236/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12988236/full.md

---
Source: https://tomesphere.com/paper/PMC12988236